Showing 120 of 120on this page. Filters & sort apply to loaded results; URL updates for sharing.120 of 120 on this page
Infographic: GiACTA - Trial of Tocilizumab in Giant-Cell Arteritis | Eye
(a) Final prednisone wallets developed and approved for the GiACTA ...
GiACTA Trial – 膠原病の歩き方
GiACTA Trial Results: Sustained Remission Rates and Flares | Download ...
OP0135 Tocilizumab in giant cell arteritis: giacta trial versus a ...
How would you taper tocilizumab in a patient treated with the GIACTA 26 ...
Baseline characteristics of GiACTA patients, stratified by disease ...
Three-year GiACTA trial results revealed - Medical Republic
Lead Investigator Discusses Implications of the GiACTA Trial for GCA ...
GiACTA Study Shows Benefit of Adding Tocilizumab to Steroid Taper in ...
Baseline features of the GIACTA cohort | Download Scientific Diagram
GiACTA Trial: Effect of the Tocilizumab on the Rates of Relapse During ...
The GiACTA Trial | New England Journal of Medicine
GiACTA Trial | 膠原病の歩き方
Giacta Prednisone Taper , The Effects of Treatment on Body Mass Index ...
GiACTA trial | Videos & Movies on Vimeo
RT @RichardPAConway: Patel @NaomiRheumMD et al. HbA1c in GiACTA ...
RT @drdavidliew: Tocilizumab in GCA - three year data from GiACTA on ...
(PDF) FRI0248 Baseline Data on Patients in Giacta (Tocilizumab in Giant ...
Étude GIACTA sur le tocilizumab en artérite | PDF | Essai clinique ...
What part 2 of the GiACTA trial means for Australia - Rheumatology Republic
Phase III GiACTA Study Shows Genentech’s Actemra® is Superior to ...
Phase III GiACTA Results Available for Giant Cell Arteritis - YouTube
GCA joint symposium ②:후생신보
Long-term effect of tocilizumab in patients with giant cell arteritis ...
Léčba obrovskobuněčné arteriitidy – současnost a o... | proLékaře.cz
Giant Cell Arteritis: Timely Diagnosis and Emerging Treatment ...
RT @ericdeinmd: #RNL2023 Year in Review New Drugs in Old Disease? GCA ...
Giant Cell Arteritis And The Rapid Rise Of Tocilizumab: Are Steroids ...
Profile of tocilizumab and its potential in the treatment of giant cel | EB
GiACTA: Giant cell arteritis remission maintained in 42% of patients ...
Full article: Safety and Efficacy of Long-Term Tocilizumab in a Cohort ...
OP0140 LONG-TERM OUTCOME OF TOCILIZUMAB FOR PATIENTS WITH GIANT CELL ...
(PDF) A Multicenter Series of Giant Cell Arteritis Patients from ...
Design of the Tocilizumab in Giant Cell Arteritis Trial - Unizony ...
(PDF) Baseline Glucocorticoid‐Related Toxicity Scores in Giant Cell ...
Metabolic bone health considerations in giant cell arteritis and ...
Measuring treatment outcomes and change in disease activity in giant ...
GCA and PMR New Drugs | RheumNow
Time to Flare in Patients with New-Onset versus Relapsing Giant Cell ...
OP0131 Optimal dose of tocilizumab for the treatment of giant cell ...
(PDF) Tocilizumab in giant cell arteritis: differences between the ...
巨細胞性動脈炎の80歳以上の患者へのTocilizumabの有効性・安全性 - 膠原病・リウマチ一人抄読会
Biologic Therapies for Giant Cell Arteritis | BTT | Dove Medical Press
SAT0275 MAINTAINED BENEFIT IN HEALTH-RELATED QUALITY OF LIFE OF ...
The Effects of Daily Prednisone and Tocilizumab on Hemoglobin A1c ...
FRI0262 CLINICAL OUTCOMES OF PATIENTS WITH GIANT CELL ARTERITIS WITH ...
Giant Cell Arteritis Actemra Trial – YAXN
Baseline Glucocorticoid‐Related Toxicity Scores in Giant Cell Arteritis ...
Baseline Glucocorticoid Toxicity in the Treatment of Giant Cell ...
FRI0220 EFFICACY OF ADJUNCTIVE METHOTREXATE IN PATIENTS WITH GIANT CELL ...
(PDF) The Effects of Treatment on Body Mass Index in Giant Cell ...
Patients’ Baseline Characteristics, but Not Tocilizumab Exposure ...
Gca And Actemra Prednisone Tapering – TOWKVJ
A rare case of giant cell arteritis affecting two giants: Pulmonary and ...
Giant Cell Arteritis Management | Evidence Evolution | AttendMe
Anterior ischemic optic neuropathy.pptx
Фармакоэкономика. Центр фармакоэкономических исследований ...
Rheum On-call Resources - RheumGuide.ca
How to Use IPFS on Brave Browser | Simplified Privacy
Giant Cell Arteritis | The Effects of Treatment on Body Mass Index in ...
Biological treatments in giant cell arteritis & Takayasu arteritis ...
The Efficacy and Safety of Tocilizumab in Patients with Giant Cell ...
Riktlinjer för utredning, behandling och uppföljning av ...
Effects of Baseline Prednisone Dose on Remission and Disease Flare in ...
In Newly Diagnosed Giant Cell Arteritis in a Real Life Setting Relapses ...
Table 3 from Design of the Tocilizumab in Giant Cell Arteritis Trial ...
Efficacy and Safety of Tocilizumab in Patients with Giant Cell ...
A JAKi in Giant Cell Arteritis: The Impact of Glucocorticoid Tapering ...
Changes in C-reactive protein (CRP) levels from baseline to 26 weeks ...
GIACT
Treatment of Giant Cell Arteritis (GCA)
Selected Vasculitides | AMBOSS Rotation Prep
Trial of Tocilizumab in Giant-Cell Arteritis | NEJM
Jacta: Track Language Learning - Apps on Google Play
Characteristics of patients with major relapse in giant cell arteritis ...
GIACT Partners With Mastercard on Digital ID and Fraud Solutions ...
PPT - GCA, Jättecellsarterit diagnos & behandling PowerPoint ...
What are the major randomized clinical trials evaluating glucocorticoid ...
RT @RichardPAConway: Patel @NaomiRheumMD et al. Baseline GTI in GCA in ...
GIACT Releases Report on Securing Faster Payments, Account Validation
Comunicación Inflamación/Enfermedades autoinmunes | Revista Clínica ...
Home - GIACT
Conference | RheumNow
Jeu de direction Clean Tapered semi-intégré 1-1/8"-1.5"
Subcutaneous Injections for GCA | ACTEMRA® (tocilizumab)
Pharmacokinetics and Pharmacodynamics of Tocilizumab in Combination ...
Classic Weft Extensions
